This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shanghai Institute of Pharmaceutical Industry, Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd., Sinopharm A-Think Pharmaceutical Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Jiajing Wang: Innovator in Histone Deacetylase Inhibitors
Introduction
Jiajing Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of histone deacetylase inhibitors. His work focuses on addressing diseases caused by abnormal gene expression.
Latest Patents
Wang holds a patent for a histone deacetylase inhibitor of benzamides. This invention is aimed at treating various diseases, including tumors, endocrine disorders, immune system diseases, genetic diseases, and nerve system diseases. The compound is characterized by a specific general chemical structural formula or a salt thereof, showcasing its potential efficacy in medical applications.
Career Highlights
Throughout his career, Jiajing Wang has worked with prominent organizations such as the Shanghai Institute of Pharmaceutical Industry and Sinopharm A-Think Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Wang has collaborated with esteemed colleagues, including Jianqi Li and Qingwei Zhang. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.
Conclusion
Jiajing Wang's contributions to the field of histone deacetylase inhibitors highlight his role as an innovator in pharmaceuticals. His work continues to pave the way for advancements in treating diseases linked to gene expression abnormalities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile